CUSIP 405024100 · who reports it, how much, and how much it matters to them
25 of the 720 hedge fund managers we track reported shares of Haemonetics Corp (NYSE: HAE) on Form 13F for 30 June 2026. Between them they reported USD 288m. The largest position belongs to Citadel Advisors, at USD 113m. The manager with the most riding on it is North Peak Capital Management, where it is 2.9% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Citadel Advisors32 funds on PPLI.com | USD 113m | 0.0% |
| 2 | Millennium Management6 funds on PPLI.com | USD 43m | 0.0% |
| 3 | Holocene Advisors2 funds on PPLI.com | USD 41m | 0.1% |
| 4 | North Peak Capital Management8 funds on PPLI.com | USD 26m | 2.9% |
| 5 | Balyasny Asset Management25 funds on PPLI.com | USD 10m | 0.0% |
| 6 | Renaissance Technologies13 funds on PPLI.com | USD 9.8m | 0.0% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 8.2m | 0.0% |
| 8 | Verition Fund Management3 funds on PPLI.com | USD 7.9m | 0.0% |
| 9 | Squarepoint Ops7 funds on PPLI.com | USD 6.5m | 0.0% |
| 10 | Bridgewater Associates45 funds on PPLI.com | USD 4.5m | 0.0% |
| 11 | Skylands Capital4 funds on PPLI.com | USD 3.6m | 0.4% |
| 12 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 2.8m | 0.1% |
| 13 | D. E. Shaw & Co.15 funds on PPLI.com | USD 2.7m | 0.0% |
| 14 | Marshall Wace LLP84 funds on PPLI.com | USD 2.3m | 0.0% |
| 15 | Nierenberg Investment Management Company3 funds on PPLI.com | USD 2m | 1.0% |
| 16 | Jain Global1 fund on PPLI.com | USD 1.1m | 0.0% |
| 17 | Grandeur Peak Global Advisors2 funds on PPLI.com | USD 989,000 | 0.2% |
| 18 | Engineers Gate Manager1 fund on PPLI.com | USD 897,000 | 0.0% |
| 19 | Two Sigma Investments35 funds on PPLI.com | USD 794,000 | 0.0% |
| 20 | Freestone Grove Partners1 fund on PPLI.com | USD 355,000 | 0.0% |
| 21 | Caxton Associates6 funds on PPLI.com | USD 257,000 | 0.0% |
| 22 | Graham Capital Management18 funds on PPLI.com | USD 208,000 | 0.0% |
| 23 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 6,911 | 0.0% |
| 24 | The Quarry1 fund on PPLI.com | USD 5,250 | 0.0% |
| 25 | Elequin Capital2 funds on PPLI.com | USD 150 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | North Peak Capital Management | USD 26m | 2.9% |
| 2 | Nierenberg Investment Management Company | USD 2m | 1.0% |
| 3 | Skylands Capital | USD 3.6m | 0.4% |
| 4 | Grandeur Peak Global Advisors | USD 989,000 | 0.2% |
| 5 | Campbell & Company Investment Adviser | USD 2.8m | 0.1% |
| 6 | Holocene Advisors | USD 41m | 0.1% |
| 7 | Verition Fund Management | USD 7.9m | 0.0% |
| 8 | Bridgewater Associates | USD 4.5m | 0.0% |
| 9 | Millennium Management | USD 43m | 0.0% |
| 10 | Citadel Advisors | USD 113m | 0.0% |
Haemonetics Corp trades under the symbol HAE on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 405024100.
25 of the 720 hedge fund managers PPLI.com tracks reported Haemonetics Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 113m), Millennium Management (USD 43m), Holocene Advisors (USD 41m), North Peak Capital Management (USD 26m) and Balyasny Asset Management (USD 10m).
25 managers in our coverage reported it, and between them they run 346 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
North Peak Capital Management, where the position was 2.9% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Haemonetics Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.